Emerging Indications for Hyperbaric Oxygen Treatment
Not yet recruitingPhase 4NCT07240649
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.
Study details
- Official title
- Emerging Indications for Hyperbaric Oxygen Treatment
- Conditions
- Post-COVID-19 Condition
- Ulcerative Colitis
- Crohn Disease
- Calciphylaxis
- Frostbite
- Acute COVID-19
- Pyoderma Gangrenosum
- Pterygium
- Hypospadias
- Head Trauma
- Pneumatosis Intestinalis
- Ischemic Bowel
- Raynaud Syndrome
- Malignant Otitis Externa
- Nonarteritic Anterior Ischemic Optic Neuropathy
- Central Retinal Vein Occlusion
- Femoral Head Necrosis
- Invasive Fungal Infection
- Chronic Anal Fissure
- Vasculitic Ulcer
- Graft-vs-Host Disease
- Decubitus Ulcer
- Greater Trochanteric Pain Syndrome
- Rectovaginal Fistula
- Pouchitis
- Tinnitus
- Clostridium Enterocolitis
- Branch Retinal Artery Occlusion
- Axonotmesis
- Multiple Sclerosis
- Inclusion Body Myositis
- Epidermolysis Bullosa (EB)
- Osteonecrosis
- Ulcer Ischemic
- Avascular Necrosis of Bone
- Prosthesis Related Infections
- Facial Filler Injections
- Cystitis Chronic
- Ligament Injury
- Anastomosis, Leaking
- Cartilage Injury
- Interventions
- Device: Hyperbaric oxygen treatment (HBOT)
- Drug: 100% Oxygen
- Sponsor
- Jay C. Buckey Jr.
- Collaborators
- Dartmouth College
- Organization
- Dartmouth-Hitchcock Medical Center
- Start date
- 2026-11
- Primary completion
- 2035-12
- Sex
- All
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients referred for HBOT with an emerging indication Exclusion Criteria: * Contraindication to hyperbaric oxygen treatment (untreated seizures, pneumothorax, significant pulmonary airspace pathology that might lead to pulmonary barotrauma, unmanageable confinement anxiety, chronic obstructive pulmonary disease with CO2 retention) * Pregnant persons
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07240649